THE NEWSROOM

Search
Categories
Archives

Investment Monitoring From Robbins LLP

To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.
protection
Robbins LLP News

Protecting the Vulnerable from Fraud

The vulnerable must always be protected, but even more so during a pandemic when increased fraud leads to a greater risk for abuse. The elderly – because of their high

Read More

Investigation of Immunomedics, Inc.

Are you a former employee of Immunomedics, Inc. (IMMU) and own stock in the company? Robbins LLP is investigating breaches of fiduciary duty by the officers and board of directors

Read More

Investigation of Ryder System, Inc.

Ryder System, Inc. (R) Accused of Misleading Shareholders  Between 2011 and 2016, Ryder overstated the residual values of certain assets between $10 million and $40 million, allowing the Company to

Read More

Investigation of Immunomedics, Inc.

Shareholder Class Action Alleging Immunomedics, Inc. (IMMU) Made Materially False and Misleading Statements Survives Motion to Dismiss On April 19, 2016, Immunomedics announced that the Company would present updated results

Read More

Investigation of PaySign, Inc.

PaySign, Inc. (PAYS) Fails to Timely File its 2019 Annual Report On March 16, 2020, PaySign announced that it would be unable to timely file its annual report for fiscal

Read More

Investigation of Evoqua Water Technologies

Shareholder Class Action Alleging Evoqua Water Technologies Corp. (AQUA) Made Materially False and Misleading Statements Survives Motion to Dismiss According to the complaint, statements in Evoqua’s initial and secondary public

Read More

Investigation of Fair Isaac Corporation

Fair Isaac Corporation (FICO) Accused of Antitrust Business Practices For roughly three decades, Fair Isaac has maintained a monopoly over the B2B Credit Score Market in the United States, largely

Read More

Investigation of Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc. (SRNE) Accused of Misleading Shareholders  On May 15, 2020, Sorrento announced that it had discovered an antibody that had “demonstrated 100% inhibition of SARS-CoV-2 virus infection” and

Read More
Skip to content